SCHEMBL14508482

SCHEMBL14508482

COc1nc2cccc(C=O)c2s1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.41
ERN1 O75460 5/20 0.40
TLR2 O60603 1/20 0.40
TLR1 Q15399 1/20 0.40
TLR6 Q9Y2C9 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
ALDH1A1 P00352 8/20 0.36
TSHR P16473 1/20 0.36
LMNA P02545 5/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
SRC P12931 1/20 0.35
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
MAPT P10636 2/20 0.34
POLB P06746 2/20 0.34
HPGD P15428 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL543240 0.78 CYP2A6 (0.44) CYP2A6ALDH1A1TSHRLMNAMEN1
SCHEMBL1908612 0.76 ALDH1A1 (0.40) ERN1ALDH1A1TSHRLMNACYP1A2
SCHEMBL23462851 0.75 CYP2A6 (0.44) CYP2A6ERN1ALDH1A1TSHRLMNA
SCHEMBL12649170 0.75 ALDH1A1 (0.45) CYP2A6ALDH1A1TSHRLMNAMEN1
SCHEMBL23462968 0.75 CYP2A6 (0.44) CYP2A6ERN1ALDH1A1TSHRLMNA
SCHEMBL5224200 0.75 KDM4E (0.39) ALDH1A1LMNACYP1A2CYP2C19MEN1
SCHEMBL13815760 0.74 ALDH1A1 (0.41) CYP2A6ERN1TLR2TLR1TLR6
SCHEMBL23462971 0.74 ALDH1A1 (0.47) CYP2A6ALDH1A1TSHRLMNACYP1A2
SCHEMBL23462856 0.73 CYP2A6 (0.40) CYP2A6ERN1CA1CA2ALDH1A1
SCHEMBL23462938 0.72 IDO1 (0.50) CYP2A6ERN1ALDH1A1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070112015-A1 Substituted dihydropyridines and methods of use CHEMOCENTRYX, INC. (US) 2007-05-17 US disclosed
US-20070112015-A1 Substituted dihydropyridines and methods of use CHEMOCENTRYX, INC. (US) 2007-05-17 US disclosed
WO-2007051062-A2 SUBSTITUTED DIHYDROPYRIDINES AND METHODS OF USE CHEMOCENTRYX, INC. (US) 2007-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112015-A1 Substituted dihydropyridines and methods of use C3AR1, C5AR1, C5AR2 CYP2A6 855/4885ERN1 3653/4885TLR2 499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.